Abacavir Sulfate Patent Expiration

Abacavir Sulfate is Used for the treatment of HIV/AIDS. It was first introduced by Viiv Healthcare Co in its drug Ziagen on Dec 17, 1998. 7 different companies have introduced drugs containing Abacavir Sulfate.


Abacavir Sulfate Patents

Given below is the list of patents protecting Abacavir Sulfate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Ziagen US6641843

(Pediatric)

Pharmaceutical compositions Aug 04, 2019

(Expired)

Viiv Hlthcare
Ziagen US6641843 Pharmaceutical compositions Feb 04, 2019

(Expired)

Viiv Hlthcare
Ziagen US6294540

(Pediatric)

Carbocyclic nucleoside hemisulfate and its use in treating viral infections Nov 14, 2018

(Expired)

Viiv Hlthcare
Ziagen US6294540 Carbocyclic nucleoside hemisulfate and its use in treating viral infections May 14, 2018

(Expired)

Viiv Hlthcare



Abacavir Sulfate's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Abacavir Sulfate Generics

Several generic applications have been filed for Abacavir Sulfate. The first generic version for Abacavir Sulfate was by Mylan Pharmaceuticals Inc and was approved on Jun 18, 2012. And the latest generic version is by Aurobindo Pharma Ltd and was approved on Mar 14, 2018.

Given below is the list of companies who have filed for Abacavir Sulfate generic.


1. APOTEX INC

Apotex Inc has filed for 1 generic for Abacavir Sulfate. Given below are the details of the strengths of this generic introduced by Apotex Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 300MG BASE tablet Discontinued ORAL N/A Dec 17, 2012


2. AUROBINDO PHARMA LTD

Aurobindo Pharma Ltd has filed for 2 different strengths of generic version for Abacavir Sulfate. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 300MG BASE tablet Prescription ORAL AB Dec 17, 2012
EQ 20MG BASE/ML solution Prescription ORAL AA Mar 14, 2018


3. CIPLA

Cipla Ltd has filed for 1 generic for Abacavir Sulfate. Given below are the details of the strengths of this generic introduced by Cipla.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 300MG BASE tablet Prescription ORAL AB Nov 21, 2017


4. HETERO LABS LTD III

Hetero Labs Ltd Unit Iii has filed for 2 different strengths of generic version for Abacavir Sulfate. Given below are the details of the strengths of this generic introduced by Hetero Labs Ltd Iii.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 300MG BASE

(reference standard)

tablet Prescription ORAL AB Sep 13, 2013
EQ 20MG BASE/ML solution Prescription ORAL AA Sep 26, 2016


5. MYLAN PHARMS INC

Mylan Pharmaceuticals Inc has filed for 1 generic for Abacavir Sulfate. Given below are the details of the strengths of this generic introduced by Mylan Pharms Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 300MG BASE tablet Prescription ORAL AB Jun 18, 2012


6. STRIDES PHARMA

Strides Pharma Global Pte Ltd has filed for 1 generic for Abacavir Sulfate. Given below are the details of the strengths of this generic introduced by Strides Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 300MG BASE tablet Prescription ORAL AB Oct 28, 2016